PharmaShots | Incisive News in 3 Shots

Subscribe Now

Altos Biologics

Altos Subsidiary of Alteogen Reports the Completion of Patient Enrollment in P-III Clinical Trial of Eylea Biosimilar for Neovascular Age-related Macular Degeneration

Altos Subsidiary of Alteogen Reports the Completion of Patient Enrollment in P-III Clinical Trial of Eylea Biosimilar for Neovascu...

February 22, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us